Organisation paid for research Program year 2025 Source: CMS Open Payments

Precision Clinical Research Inc

Neither a doctor nor a teaching hospital

Research payments

$1,119,109

1,066 payments

Through program year 2025, Precision Clinical Research Inc is reported as receiving $1,119,109 in research payments, across 1,066 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2025	Research	$384,997	227
2024	Research	$409,349	548
2023	Research	$186,617	194
2022	Research	$138,146	97

Breakdown

Who paid Research payments · program years 2022–2025

Seqirus USA Inc $1,119,109 1,066 payments

Studies the money was for Research payments · program years 2022–2025

The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older $503,399 393 payments
A Phase 3/3b Randomized Observer-blind Multicenter Clinical Study to Evaluate the Efficacy Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Subunit Inactivated Influenza Vaccine Compared to a Non-Influenza Vaccine in Adults >=50 Years of Age $321,837 163 payments
A Phase 2b, Randomized, Observer-Blind, Antigen and Adjuvant Dose-Confirmation Clinical Study to Evaluate Safety and Immunogenicity of Different Formulations of MF59-Adjuvanted Quadrivalent Subunit Inactivated Cell-derived Influenza Vaccine (aQIVc) in Older Adults =50 Years of Age $218,646 413 payments
Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults $61,256 93 payments
A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compared to a Non-adjuvanted Influenza Vaccine in Adults 65 Years of Age $13,972 4 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.